Literature DB >> 8744397

APP transgenesis: approaches toward the development of animal models for Alzheimer disease neuropathology.

B D Greenberg1, M J Savage, D S Howland, S M Ali, S L Siedlak, G Perry, R Siman, R W Scott.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8744397     DOI： 10.1016/0197-4580(96)00001-2

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN： 0197-4580            Impact factor:   4.673


× No keyword cloud information.
  6 in total

Review 1.  Vaccines for Alzheimer's disease: how close are we?

Authors:  Christopher Janus
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

2.  Does overexpression of betaAPP in aging muscle have a pathogenic role and a relevance to Alzheimer's disease? Clues from inclusion body myositis, cultured human muscle, and transgenic mice.

Authors:  V Askanas; W K Engel
Journal:  Am J Pathol       Date:  1998-12       Impact factor: 4.307

Review 3.  Immunotherapy for Alzheimer's disease.

Authors:  D Morgan
Journal:  J Intern Med       Date:  2011-01       Impact factor: 8.989

Review 4.  Learning and memory deficits in APP transgenic mouse models of amyloid deposition.

Authors:  Dave Morgan
Journal:  Neurochem Res       Date:  2003-07       Impact factor: 3.996

5.  Ginsennoside rd attenuates cognitive dysfunction in a rat model of Alzheimer's disease.

Authors:  Juanfang Liu; Xiaodong Yan; Ling Li; Yi Zhu; Kefeng Qin; Linfu Zhou; Dong Sun; Xiaohui Zhang; Ruidong Ye; Gang Zhao
Journal:  Neurochem Res       Date:  2012-08-18       Impact factor: 3.996

Review 6.  Review: experimental manipulations of microglia in mouse models of Alzheimer's pathology: activation reduces amyloid but hastens tau pathology.

Authors:  D C Lee; J Rizer; J B Hunt; M-L B Selenica; M N Gordon; D Morgan
Journal:  Neuropathol Appl Neurobiol       Date:  2013-02       Impact factor: 8.090
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.